Trial Details
TERMINATEDBasic Information
| Clinical ID | c4557 |
|---|---|
| Identifier | NCT00329537 |
| Trial Title | Study of Sargramostim in Moderately to Severely Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Sargramostim (Leukine)|DRUG: Placebo |
Participant Information
| Sponsor | Genzyme, a Sanofi Company |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2006-06 |
|---|---|
| Primary Completion Date | 2007-05 |
| Completion Date | 2007-05 |